Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $1.81 Million - $2.04 Million
6,333 New
6,333 $1.83 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $59,679 - $74,307
254 Added 7.17%
3,797 $1.07 Million
Q1 2022

May 12, 2022

BUY
$221.42 - $260.97 $784,491 - $924,616
3,543 New
3,543 $925,000
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $376,166 - $466,626
-1,883 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $313,914 - $421,622
1,883 New
1,883 $412,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.